leisure time -WSS

leisure time

author：knowledge 2025-09-06 03:57:01 - browse：9

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： At flashy new research hub, AstraZeneca lays out ambitious growth goals

leisure time

WSS

Laying a path for careers in science

Liver decline slowed by off

Cue Health, Covid

Doctor of U.S. President Joe Biden says he is fit for duty

CDC panel: People 65 and older should get a Covid spring booster shot

H5N1 bird flu outbreak: Second human case reported, in Michigan

entertainment

leisure time

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Children’s Hospital revives plan for pedestrian bridge

Medicare details structure of new drug price negotiation program

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

At least 13 dead in Texas as scorching temps continue

Elisabeth Bik tackles the widespread issue of research misconduct

Trump demands the U.S. pay no more for drugs than other countries … again

Redefining sustainability for the pharmaceutical industry

explore

Reports of telehealth's death have been greatly exaggerated

Redefining sustainability for the pharmaceutical industry

Pfizer is about to make a big push in cancer. Will investors listen?

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Virtual repurposing can help discover new uses for existing drugs

For longer

explore

explore

leisure time

focus